Target intelligence / Profile preview

Nausea pathways

Molecular classification
G protein-coupled receptor, Ion channel, Neurotransmitter system, Other
01

Overview

Nausea pathways represent a complex physiological network responsible for the sensation of nausea and the reflex of vomiting. These pathways integrate signals from the gastrointestinal tract via the vagus nerve, the vestibular system, and the chemoreceptor trigger zone (CTZ) located in the area postrema of the medulla (NCBI, Neurobiology of Nausea and Vomiting, 2014). Key molecular mediators include serotonin acting on 5-HT3 receptors, substance P acting on NK1 receptors, dopamine acting on D2 receptors, histamine acting on H1 receptors, and acetylcholine acting on M1 receptors (StatPearls, Antiemetic Medications, 2023). Activation of these receptors leads to the stimulation of the central vomiting center, which coordinates the muscular actions of emesis. Pharmacological intervention typically involves blocking one or more of these receptor types to prevent or treat conditions like chemotherapy-induced nausea and vomiting (CINV), postoperative nausea and vomiting (PONV), or motion sickness (Mayo Clinic, Nausea and Vomiting, 2023). Because this term describes a collection of biological processes and multiple distinct molecular targets rather than a single protein, it is classified as a pathway rather than a specific therapeutic target.

Other names
Emetic reflexVomiting pathwaysChemoreceptor trigger zone signalingNausea and vomiting of pregnancy pathwaysCentral and peripheral emetic circuits
02

Mechanism of action

Antagonism of specific receptors within the pathway, including 5-HT3, NK1, D2, H1, and M1 receptors, to inhibit the transmission of emetic signals to the vomiting center in the medulla (StatPearls, Physiology, Vomiting, 2023).

03

Biological functions

Signal transductionSensory perceptionEmesisHomeostasisOther
04

Disease associations

Chemotherapy-induced nausea and vomitingPostoperative nausea and vomitingMotion sicknessGastroparesisOther
05

Safety considerations

QT prolongationExtrapyramidal symptomsSedationConstipationDizzinessHeadache
06

Interacting drugs

Ondansetron

9 more in the full profile.

07

Biomarkers

Visual Analog Scale (VAS) for nauseaRhodes Index of Nausea, Vomiting and RetchingGastric emptying rateElectrogastrography (EGG) rhythms

Beyond the preview

Go deeper on Nausea pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nausea pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call